- Home
- DXR vs NXPL Comparison
DXR vs NXPL Comparison
Compare DXR & NXPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXR
- NXPL
- Stock Information
- Founded
- DXR 1970
- NXPL 1997
- Country
- DXR United States
- NXPL United States
- Employees
- DXR N/A
- NXPL N/A
- Industry
- DXR Medical/Dental Instruments
- NXPL Telecommunications Equipment
- Sector
- DXR Health Care
- NXPL Telecommunications
- Exchange
- DXR Nasdaq
- NXPL Nasdaq
- Market Cap
- DXR 37.6M
- NXPL 32.5M
- IPO Year
- DXR N/A
- NXPL N/A
- Fundamental
- Price
- DXR $7.24
- NXPL $0.98
- Analyst Decision
- DXR Strong Buy
- NXPL
- Analyst Count
- DXR 1
- NXPL 0
- Target Price
- DXR $24.75
- NXPL N/A
- AVG Volume (30 Days)
- DXR 5.7K
- NXPL 83.2K
- Earning Date
- DXR 01-01-0001
- NXPL 04-10-2025
- Dividend Yield
- DXR N/A
- NXPL N/A
- EPS Growth
- DXR N/A
- NXPL N/A
- EPS
- DXR 0.35
- NXPL N/A
- Revenue
- DXR $154,205.00
- NXPL $66,482,000.00
- Revenue This Year
- DXR N/A
- NXPL N/A
- Revenue Next Year
- DXR N/A
- NXPL N/A
- P/E Ratio
- DXR $20.78
- NXPL N/A
- Revenue Growth
- DXR N/A
- NXPL 179.89
- 52 Week Low
- DXR $6.55
- NXPL $0.71
- 52 Week High
- DXR $10.00
- NXPL $2.68
- Technical
- Relative Strength Index (RSI)
- DXR 37.76
- NXPL 43.52
- Support Level
- DXR $7.00
- NXPL $0.96
- Resistance Level
- DXR $7.49
- NXPL $1.12
- Average True Range (ATR)
- DXR 0.33
- NXPL 0.09
- MACD
- DXR -0.01
- NXPL -0.00
- Stochastic Oscillator
- DXR 44.44
- NXPL 39.13
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.